Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-12-06 4:30 pm Purchase | 2022-12-02 | 13D | Solid Biosciences Inc. SLDB | PERCEPTIVE ADVISORS LLC | 3,501,265 17.900% | 2,603,762 (+290.11%) | Filing History |
| 2022-12-05 5:12 pm Purchase | 2022-12-02 | 13D | Solid Biosciences Inc. SLDB | RA CAPITAL MANAGEMENT L.P. | 3,431,618 17.570% | 2,601,760 (+313.52%) | Filing History |
| 2022-12-05 4:28 pm Purchase | 2022-12-02 | 13D | Solid Biosciences Inc. SLDB | BCLS SB Investco, LP | 2,301,955 11.800% | 1,773,294 (+335.43%) | Filing History |
| 2022-10-04 5:14 pm Unchanged | 2022-09-29 | 13D | Solid Biosciences Inc. SLDB | RA CAPITAL MANAGEMENT L.P. | 829,858 11.010% | 0 (Unchanged) | Filing History |
| 2022-10-03 5:11 pm Unchanged | 2022-09-29 | 13D | Solid Biosciences Inc. SLDB | BCLS SB Investco, LP | 528,661 7.000% | 0 (Unchanged) | Filing History |
| 2022-09-06 4:50 pm Purchase | 2022-09-02 | 13D | Solid Biosciences Inc. SLDB | RA CAPITAL MANAGEMENT L.P. | 829,858 11.010% | 5,333 (+0.65%) | Filing History |
| 2022-09-02 4:50 pm Purchase | 2022-09-02 | 13D | Solid Biosciences Inc. SLDB | PERCEPTIVE ADVISORS LLC | 897,503 11.900% | 3,333 (+0.37%) | Filing History |
| 2022-08-31 5:49 pm Purchase | 2022-08-29 | 13G | Solid Biosciences Inc. SLDB | K2 PRINCIPAL FUND L.P. | 380,613 5.050% | 380,613 (New Position) | Filing History |
| 2022-08-18 4:55 pm Unchanged | 2022-08-18 | 13D | Solid Biosciences Inc. SLDB | BCLS SB Investco, LP | 528,661 7.000% | 0 (Unchanged) | Filing History |
| 2022-07-08 4:56 pm Sale | 2022-06-30 | 13G | Solid Biosciences Inc. SLDB | BlackRock Inc. BLK | 191,242 2.500% | -225,638 (-54.13%) | Filing History |
| 2022-02-14 4:40 pm Sale | 2021-12-31 | 13G | Solid Biosciences Inc. SLDB | Boxer Capital LLC | 355,735 4.700% | -57,615 (-13.94%) | Filing History |
| 2022-02-14 3:19 pm Purchase | 2021-12-31 | 13G | Solid Biosciences Inc. SLDB | EcoR1 Capital, LLC | 613,513 8.300% | 81,667 (+15.36%) | Filing History |
| 2022-02-11 5:20 pm Purchase | 2021-12-31 | 13G | Solid Biosciences Inc. SLDB | SUVRETTA CAPITAL MANAGEMENT, LLC | 419,146 5.700% | 20,867 (+5.24%) | Filing History |
| 2022-02-04 4:12 pm Purchase | 2021-12-31 | 13G | Solid Biosciences Inc. SLDB | BlackRock Inc. BLK | 416,881 5.700% | 416,881 (New Position) | Filing History |
| 2021-03-29 4:35 pm Purchase | 2021-03-19 | 13G | Solid Biosciences Inc. SLDB | SUVRETTA CAPITAL MANAGEMENT, LLC | 398,280 5.400% | 398,280 (New Position) | Filing History |
| 2021-03-25 4:32 pm Purchase | 2021-03-23 | 13D | Solid Biosciences Inc. SLDB | BCLS SB Investco, LP | 528,661 7.400% | 57,971 (+12.32%) | Filing History |
| 2021-03-23 5:15 pm Purchase | 2021-03-23 | 13D | Solid Biosciences Inc. SLDB | PERCEPTIVE ADVISORS LLC | 894,170 12.500% | 173,913 (+24.15%) | Filing History |
| 2021-03-23 4:32 pm Purchase | 2009-02-28 | 13D | Solid Biosciences Inc. SLDB | RA CAPITAL MANAGEMENT L.P. | 824,525 11.600% | 159,420 (+23.97%) | Filing History |